Acute and long-term effects of botulinum neurotoxin on the function and structure of developing extraocular muscles

Neurobiology of Disease

Volumn 25, Issue 3, 2007, Pages 649-664

  Croes, Scott A ^a   Baryshnikova, Larisa M ^a   Kaluskar, Soniya S ^a   von Bartheld, Christopher S ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

Botulinum toxin; Contractile force; Eye muscle; Mitochondria; Motor endplate; Neuromuscular junction; Oculomotor; Strabismus

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHICKEN; CONTROLLED STUDY; EXTRAOCULAR MUSCLE; FEMALE; HATCHLING; MITOCHONDRION; MORPHOMETRICS; MOUSE; MUSCLE CELL; MUSCLE CONTRACTILITY; MUSCLE CONTRACTION; MUSCLE DEVELOPMENT; MUSCLE STRENGTH; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SUPERIOR OBLIQUE MUSCLE; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; BOTULINUM TOXIN TYPE A; CHICK EMBRYO; CHICKENS; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA; MOTOR ENDPLATE; MUSCLE CONTRACTION; MUSCLE FATIGUE; MUSCLE FIBERS; NEUROTOXINS; OCULOMOTOR MUSCLES; RECOVERY OF FUNCTION; STRABISMUS;

EID: 33847332607     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2006.11.007     Document Type: Article

References (79)

1. Alderson K., Holds J.B., and Anderson R.L. Botulinum-induced alteration of nerve-muscle interactions in the human orbicularis oculi following treatment for blepharospasm. Neurology 41 (1991) 1800-1805
2. Angaut-Petit D., Molgo J., Comella J.X., Faille L., and Tabti N. Terminal sprouting in mouse neuromuscular junctions poisoned with botulinum type A toxin: morphological and electrophysiological features. Neuroscience 37 (1990) 799-808
3. Aoki K.R. A comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in mice. Toxicon 39 (2001) 1815-1820
4. Asmussen G. The properties of the extraocular muscles of the frog. I. Mechanical properties of the isolated superior oblique and superior rectus muscles. Acta Biol. Med. Ger. 37 (1978) 301-312
5. Balice-Gordon R.J., and Lichtman J.W. In vivo observations of pre- and postsynaptic changes during the transition from multiple to single innervation at developing neuromuscular junctions. J. Neurosci. 13 (1993) 834-855
6. Balice-Gordon R.J., Breedlove S.M., Bernstein S., and Lichtman J.W. Neuromuscular junctions shrink and expand as muscle fiber size is manipulated: in vivo observations in the androgen-sensitive bulbocavernosus muscle of mice. J. Neurosci. 10 (1990) 2660-2671
7. Bambrick L., and Gordon T. Acetylcholine receptors and sodium channels in denervated and botulinum-toxin-treated adult rat muscle. J. Physiol. 382 (1987) 69-86
8. Barmack N.H., Bell C.C., and Rence B.G. Tension and rate of tension development during isometric responses of extraocular muscle. J. Neurophysiol. 34 (1971) 1072-1079
9. Baryshnikova, L.M., Croes, S.A., von Bartheld C.S., submitted for publication. Classification and development of myofiber types in chicken extraocular muscles. Anat. Rec. A Discov. Mol. Cell. Evol. Biol.
10. Biglan A.W., Burnstine R.A., Rogers G.L., and Saunders R.A. Management of strabismus with botulinum A toxin. Ophthalmology 96 (1989) 935-943
11. Birch E.E., Stager D.R., Berry P., and Everett M.E. Prospective assessment of acuity and stereopsis in amblyopic infantile esotropes following early surgery. Invest. Ophthalmol. Visual Sci. 31 (1990) 758-765
12. Brin M.F. Dosing, administration, and a treatment algorithm for use of botulinum toxin A for adult-onset spasticity. Spasticity Study Group. Muscle Nerve 6 (1997) 208-220
13. Brin M.F., and Blitzer A. Botulinum toxin: dangerous terminology errors. J. R. Soc. Med. 86 (1993) 493-494
14. Brown M.C., Holland R.L., and Ironton R. Nodal and terminal sprouting from motor nerves in fast and slow muscles of the mouse. J. Physiol. 306 (1980) 493-510
15. Calace P., Cortese G., Piscopo R., et al. Treatment of blepharospasm with botulinum neurotoxin type A: long-term results. Eur. J. Ophthalmol. 13 (2003) 331-336
16. Campos E.C., Schiavi C., and Bellusci C. Critical age of botulinum toxin treatment in essential infantile esotropia. J. Pediatr. Ophthalmol. Strabismus 37 (2000) 328-332
17. Capetanaki Y. Desmin cytoskeleton: a potential regulator of muscle mitochondrial behavior and function. Trends Cardiovasc. Med. 12 (2002) 339-348
18. Chen J., and von Bartheld C.S. Role of exogenous and endogenous trophic factors in the regulation of extraocular muscle strength during development. Invest. Ophthalmol. Visual Sci. 45 (2004) 3538-3545
19. Christiansen S.P., Becker B.A., Iaizzo P.A., and McLoon L.K. Extraocular muscle force generation after ricin-mAb35 injection: implications for strabismus treatment. J. AAPOS 7 (2003) 1-6
20. Croes S.A., and von Bartheld C.S. Development of the neuromuscular junction in extraocular muscles of white Leghorn chicks. Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 282 (2005) 110-119
21. Croes, S.A., von Bartheld C.S., submitted for publication. Measurement of contractile force of skeletal and extraocular muscles: effects of blood supply, age, and in situ preparation. J. Neurosci. Methods.
22. Defazio G., Abbruzzese G., Girlanda P., et al. Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study. Arch. Neurol. 59 (2002) 418-420
23. Demer J.L., Miller J.M., Poukens V., Vinters H.V., and Glasgow B.J. Evidence for fibromuscular pulleys of the recti extraocular muscles. Invest. Ophthalmol. Visual Sci. 36 (1995) 1125-1136
24. Demer J.L., Poukens V., Miller J.M., and Micevych P. Innervation of extraocular pulley smooth muscle in monkeys and humans. Invest. Ophthalmol. Visual Sci. 38 (1997) 1774-1785
25. Demer J.L., Oh S.Y., and Poukens V. Evidence for active control of rectus extraocular muscle pulleys. Invest. Ophthalmol. Visual Sci. 41 (2000) 1280-1290
26. de Paiva A., Meunier F.A., Molgo J., Aoki K.R., and Dolly J.O. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 3200-3205
27. Dimitrova D.M., Shall M.S., and Goldberg S.J. Short-term effects of botulinum toxin on the lateral rectus muscle of cat. Exp. Brain Res. 147 (2002) 449-455
28. Drew B., and Leeuwenburgh C. Ageing and subcellular distribution of mitochondria: role of mitochondrial DNA deletions and energy production. Acta Physiol. Scand. 182 (2004) 333-341
29. Duchen L.W. Changes in motor innervation and cholinesterase localization induced by botulinum toxin in skeletal muscle of the mouse: differences between fast and slow muscles. J. Neurol. Neurosurg. Psychiatry 33 (1970) 40-54
30. Duchen L.W., and Strich S.J. The effects of botulinum toxin on the pattern of innervation of skeletal muscle in the mouse. Q. J. Exp. Physiol. Cogn. Med. Sci. 53 (1968) 84-89
31. Fenstemaker S.B., Kiorpes L., and Movshon J.A. Effects of experimental strabismus on the architecture of macaque monkey striate cortex. J. Comp. Neurol. 438 (2001) 300-317
32. Fluck M., and Hoppeler H. Molecular basis of skeletal muscle plasticity-from gene to form and function. Rev. Physiol. Biochem. Pharmacol. 146 (2003) 159-216
33. Goldberg S.J., Meredith M.A., and Shall M.S. Extraocular motor unit and whole-muscle responses in the lateral rectus muscle of the squirrel monkey. J. Neurosci. 18 (1998) 10629-10639
34. Heaton M.B., and Wayne D.B. Patterns of extraocular innervation by the oculomotor complex in the chick. J. Comp. Neurol. 216 (1983) 245-252
35. Holds J.B., Alderson K., Fogg S.G., and Anderson R.L. Motor nerve sprouting in human orbicularis muscle after botulinum A injection. Invest. Ophthalmol. Visual Sci. 31 (1990) 964-967
36. Holland R.L., and Brown M.C. Nerve growth in botulinum toxin poisoned muscles. Neuroscience 6 (1981) 1167-1179
37. Hoppeler H., Hudlicka O., and Uhlmann E. Relationship between mitochondria and oxygen consumption in isolated cat muscles. J. Physiol. 385 (1987) 661-675
38. Horn A.K., Porter J.D., and Evinger C. Botulinum toxin paralysis of the orbicularis oculi muscle. Types and time course of alterations in muscle structure, physiology and lid kinematics. Exp. Brain Res. 96 (1993) 39-53
39. Hubel D.H., and Wiesel T.N. Binocular interaction in striate cortex of kittens reared with artificial squint. J. Neurophysiol. 28 (1965) 1041-1059
40. Ing M.R. Early surgical alignment for congenital esotropia. Trans. Am. Ophthalmol. Soc. 79 (1981) 625-663
41. Ing M.R. Botulinum alignment for congenital esotropia. Ophthalmology 100 (1993) 318-322
42. Kedlaya, D., 2004. Botulinum toxin: overview. eMedicine (cited 2004 Nov 15). Available from http://www.emedicine.com/pmr/topic216.htm
43. Kind P.C., Mitchell D.E., Ahmed B., Blakemore C., Bonhoeffer T., and Sengpiel F. Correlated binocular activity guides recovery from monocular deprivation. Nature 416 (2002) 430-433
44. Kranjc B.S., Sketelj J., D'Albis A., and Erzen I. Long-term changes in myosin heavy chain composition after botulinum toxin a injection into rat medial rectus muscle. Invest. Ophthalmol. Visual Sci. 42 (2001) 3158-3164
45. Lee J., Elston J., Vickers S., Powell C., Ketley J., and Hogg C. Botulinum toxin therapy for squint. Eye 2 (1988) 24-28
46. Ma J., Elsaidi G.A., Smith T.L., Walker F.O., Tan K.H., Martin E., Koman L.A., and Smith B.P. Time course of recovery of juvenile skeletal muscle after botulinum toxin A injection: an animal model study. Am. J. Phys. Med. Rehabil. 83 (2004) 774-780
47. Magoon E.H. Chemodenervation of strabismic children. A 2- to 5-year follow-up study compared with shorter follow-up. Ophthalmology 96 (1989) 931-934
48. Magramm I. Amblyopia: etiology, detection, and treatment. Pediatr. Rev. 13 (1992) 7-14
49. Maier A., Eldred E., and Edgerton V.R. Types of muscle fibers in the extraocular muscles of birds. Exp. Eye Res. 13 (1972) 255-265
50. Marques M.J., Conchello J.-A., and Lichtman J.W. From plaque to pretzel: fold formation and acetylcholine receptor loss at the developing neuromuscular junction. J. Neurosci. 20 (2000) 3663-3675
51. Mayr R. Structure and distribution of fiber types in the external eye muscles of the rat. Tissue Cell 3 (1971) 433-462
52. McNeer K.W., Tucker M.G., and Spencer R.F. Management of essential infantile esotropia with botulinum toxin A: review and recommendations. J. Pediatr. Ophthalmol. Strabismus 37 (2000) 63-67
53. McNeer K.W., Tucker M.G., Guerry C.H., and Spencer R.F. Incidence of stereopsis after treatment of infantile esotropia with botulinum toxin A. J. Pediatr. Ophthalmol. Strabismus 40 (2003) 288-292
54. Moreno-Lopez B., de la Cruz R.R., Pastor A.M., and Delgado-Garcia J.M. Effects of botulinum neurotoxin type A on abducens motoneurons in the cat: alterations of the discharge pattern. Neuroscience 81 (1997) 437-455
55. Oda K. Motor innervation and acetylcholine receptor distribution of human extraocular muscle fibres. J. Neurol. Sci. 74 (1986) 125-133
56. Oda K., and Hiroshi S. Antigenic differences of acetylcholine receptor between single and multiple form endplates of human extraocular muscle. Brain Res. 449 (1988) 337-340
57. Ohtsuki H., Hasebe S., Okano M., and Furuse T. Morphological changes in the orbital surface layer muscle of the rabbit eye produced by botulinum toxin. Ophthalmologica 212 (1998) 53-60
58. Pearce L.B., Borodic G.E., Johnson E.A., First E.R., and MacCallum R.D. The median paralysis unit: a more pharmacologically relevant unit of biologic activity for botulinum toxin. Toxicon 33 (1995) 217-227
59. Porter J.D., and Baker R.S. Muscles of a different 'color': the unusual properties of the extraocular muscles may predispose or protect them in neurogenic and myogenic disease. Neurology 46 (1996) 30-37
60. Porter J.D., Strebeck S., and Capra N.F. Botulinum-induced changes in monkey eyelid muscle. Comparison with changes seen in extraocular muscle. Arch. Ophthalmol. 109 (1991) 396-404
61. Porter J.D., Baker R.S., Ragusa R.J., and Brueckner J.K. Extraocular muscles: basic and clinical aspects of structure and function. Surv. Ophthalmol. 39 (1995) 451-484
62. Porter J.D., Poukens V., Baker R.S., and Demer J.L. Structure-function correlations in the human medial rectus extraocular muscle pulleys. Invest. Ophthalmol. Visual Sci. 37 (1996) 468-472
63. Sanes J.R., and Lichtman J.W. Development of the vertebrate neuromuscular junction. Annu. Rev. Neurosci. 22 (1999) 389-442
64. Schantz E.J., and Johnson E.A. Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol. Rev. 56 (1992) 80-99
65. Scott A.B. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 87 (1980) 1044-1049
66. Scott A.B., Rosenbaum A., and Collins C.C. Pharmacologic weakening of extraocular muscles. Invest. Ophthalmol. 12 (1973) 924-927
67. Shaari C.M., George E., Wu B.L., Biller H.F., and Sanders I. Quantifying the spread of botulinum toxin through muscle fascia. Laryngoscope 101 (1991) 960-964
68. Sloop R.R., Cole B.A., and Escutin R.O. Reconstituted botulinum toxin type A does not lose potency in humans if it is refrozen or refrigerated for 2 weeks before use. Neurology 48 (1997) 249-253
69. Spencer R.F., and McNeer K.W. Botulinum toxin paralysis of adult monkey extraocular muscle. Structural alterations in orbital, singly innervated muscle fibers. Arch. Ophthalmol. 105 (1987) 1703-1711
70. Spencer R.F., and Porter J.D. Structural organization of the extraocular muscles. Rev. Oculomot. Res. 2 (1988) 33-79
71. Spencer R.F., Tucker M.G., McNeer K.W., and Porter J.D. Experimental studies of pharmacological and surgical denervation of extraocular muscles in adult and infant monkeys. In: Scott A.B. (Ed). Trans Symposium "Mechanics of Strabismus." San Francisco, Calif (1992) 207-227
72. Stahl J.S., Averbuch-Heller L., Remler B.F., and Leigh R.J. Clinical evidence of extraocular muscle fiber-type specificity of botulinum toxin. Neurology 51 (1998) 1093-1099
73. Stelling J., and McVean A. The contractile properties and movement dynamics of pigeon eye muscle. Pflugers Arch. 412 (1988) 314-321
74. Stidwill D. Epidemiology of strabismus. Ophthalmic Physiol. Opt. 17 (1997) 536-539
75. Tejedor J., and Rodriguez J.M. Long-term outcome and predictor variables in the treatment of acquired esotropia with botulinum toxin. Invest. Ophthalmol. Visual Sci. 42 (2001) 2542-2546
76. Tychsen L.F. Strabismus: the scientific basis. Chapter 76. In: Taylor D.H., and Hoyt C.S. (Eds). Pediatric Ophthalmology and Strabismus. 3rd ed. (2005), Elsevier-Saunders
77. von Bartheld C.S. Radio-iodination of neurotrophins and their delivery in vivo: advantages of membrane filtration and the use of disposable syringes. J. Neurosci. Methods 79 (1998) 207-215
78. Wasicky R., Ziya-Ghazvini F., Blumer R., Lukas J.R., and Mayr R. Muscle fiber types of human extraocular muscles: a histochemical and immunohistochemical study. Invest. Ophthalmol. Visual Sci. 41 (2000) 980-990
79. Witzemann V., Brenner H.R., and Sakmann B. Neural factors regulate AChR subunit mRNAs at rat neuromuscular synapses. J. Cell Biol. 114 (1991) 125-141